Avidity Biosciences, Inc.

NasdaqGM:RNA Stock Report

Market Cap: US$5.0b

Avidity Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:RNA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Aug 24BuyUS$233,989,679RTW Investments, LPCompany5,129,103US$45.62
22 Aug 24SellUS$532,814,925RTW Investments, LPCompany11,425,730US$46.63
18 Jun 24SellUS$385,972Teresa McCarthyIndividual9,864US$39.13
03 Apr 24SellUS$542,214Arthur LevinIndividual20,000US$27.11
12 Mar 24SellUS$58,102Arthur LevinIndividual2,641US$22.00
26 Jan 24BuyUS$2,152,651RTW Investments, LPCompany207,780US$10.49
22 Jan 24SellUS$16,370Michael MacLeanIndividual1,616US$10.13
22 Jan 24SellUS$20,918Teresa McCarthyIndividual2,065US$10.13
22 Jan 24SellUS$120,173RTW Investments, LPCompany11,700US$10.27

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RNA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders490,9340.381%
Public Companies5,075,3043.94%
VC/PE Firms6,300,4084.89%
Hedge Funds15,007,87011.6%
Institutions102,070,50879.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 61%.

Top Shareholders

Top 25 shareholders own 90.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.1%
FMR LLC
16,848,717US$710.7m4.27%0.05%
8.91%
T. Rowe Price Group, Inc.
10,633,962US$448.5m-2.59%0.05%
7.73%
The Vanguard Group, Inc.
9,226,884US$389.2m55.2%0.01%
7.23%
BlackRock, Inc.
8,622,513US$363.7m0%0.01%
6.82%
RTW Investments, LP
8,132,870US$343.0m-7.65%5.73%
5.89%
Wellington Management Group LLP
7,030,949US$296.6m84.9%0.06%
5.76%
Avoro Capital Advisors LLC
6,875,000US$290.0m5.69%4.71%
5.28%
RA Capital Management, L.P.
6,300,408US$265.8m16.7%3.81%
4.25%
Bristol-Myers Squibb Company
5,075,304US$214.1m0%no data
3.94%
State Street Global Advisors, Inc.
4,706,106US$198.5m41.8%0.01%
3.07%
Janus Henderson Group plc
3,656,843US$154.2m0%0.08%
2.58%
Adage Capital Management, L.P.
3,079,374US$129.9m-9.35%0.27%
2.17%
Geode Capital Management, LLC
2,585,303US$109.0m14.6%0.01%
1.75%
Casdin Capital, LLC
2,084,841US$87.9m0%6.56%
1.45%
Tavistock Life Sciences
1,727,388US$72.9m0%5.46%
1.29%
Polar Capital Holdings Plc
1,542,126US$65.0m38.4%0.3%
1.21%
The Invus Group, LLC
1,440,736US$60.8m0%3.33%
1.11%
Artisan Partners Limited Partnership
1,329,279US$56.1m-30.1%0.05%
1.04%
Bank of America Corporation, Asset Management Arm
1,238,732US$52.2m647%0.02%
0.93%
D. E. Shaw & Co., L.P.
1,108,647US$46.8m50%0.08%
0.89%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,058,560US$44.7m-11.7%0.01%
0.88%
Cormorant Asset Management, LP
1,050,000US$44.3m147%2.48%
0.88%
OrbiMed Advisors LLC
1,044,805US$44.1m47.9%0.73%
0.83%
Charles Schwab Investment Management, Inc.
990,182US$41.8m24.9%0.01%
0.81%
Northern Trust Global Investments
971,131US$41.0m27.8%0.01%